https://european-biotechnology.com/wp-content/uploads/2024/04/Evonik.jpg8861181Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-03-18 05:38:002020-03-18 05:38:00Evonik Industries AG establishes production of recombinant collagen
Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.
Researchers at Swiss pharma giant Roche AG have found a subpopulation of dendritic cells to determine how cancer patients respond to immune checkpoint inhibitors.
FGK Clinical Research GmbH opens a branch office in Berlin this month. The Berlin office will support the operative units at the German headquarters in Munich.
https://european-biotechnology.com/wp-content/uploads/2024/04/EBM_11_03_20_FGK.jpg10321835Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-03-11 14:27:212024-04-02 16:20:33CRO opens new branch office in Berlin
https://european-biotechnology.com/wp-content/uploads/2024/04/1024px-E_coli_at_10000x__original.jpg7451024Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-03-10 08:37:002020-03-10 08:37:00Nutrition influences the course of MS
https://european-biotechnology.com/wp-content/uploads/2024/04/GeldLSP.jpg9721280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-03-09 09:00:002020-03-09 09:00:00LSP launches US-$600m European life sciences fund
https://european-biotechnology.com/wp-content/uploads/2024/04/Biotalys.png5381125Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-03-05 09:38:402020-03-05 09:38:40Biotalys grabs €45m in Series C financing
Researchers from German Fraunhofer IGBI have used next-generation sequencing (NGS) to diagnosis sepsis from tiny amounts of microbial DNA in the blood.
https://european-biotechnology.com/wp-content/uploads/2024/04/Minion.jpg263395Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-03-05 07:45:002020-03-05 07:45:00German and UK researchers cut time to sepsis diagnosis
Evonik Industries AG establishes production of recombinant collagen
Latest NewsEvonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.
BioNTech SE’s COVID-19 vaccine attracts investment
Latest NewsChinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTech’d mRNA vaccine BNT162.
Commission relaunches circular economy action plan
Latest NewsUnder its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.
Roche unravel biomarker for checkpoint blockade
Latest NewsResearchers at Swiss pharma giant Roche AG have found a subpopulation of dendritic cells to determine how cancer patients respond to immune checkpoint inhibitors.
CRO opens new branch office in Berlin
BackgroundFGK Clinical Research GmbH opens a branch office in Berlin this month. The Berlin office will support the operative units at the German headquarters in Munich.
Nutrition influences the course of MS
Latest NewsNew data prove that propionic acid modulates the intestine-mediated immune regulation in people with multiple sclerosis (MS).
LSP launches US-$600m European life sciences fund
Latest NewsLSP has closed its LSP 6 fund at the $600m hard cap. It is the largest fund ever raised in Europe focused on life sciences ventures.
Biotalys grabs €45m in Series C financing
Latest NewsPest control specialist Biotalys NV has raised an additional €10m to its series C financing bringing its amount to €45m.
Solentim: Aiming for growth
AppointmentsMark Truesdale has been appointed to the position of CEO at Life Sciences company Solentim.
German and UK researchers cut time to sepsis diagnosis
Latest NewsResearchers from German Fraunhofer IGBI have used next-generation sequencing (NGS) to diagnosis sepsis from tiny amounts of microbial DNA in the blood.